# OnCo record elias-jabbour (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/elias-jabbour/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "elias-jabbour" ;
  schema:name "Elias Jabbour"@en ;
  schema:description "Leukaemia specialist who built chemotherapy-light regimens combining inotuzumab, blinatumomab and ponatinib for adult ALL."@en ;
  schema:url <https://onco.cc/people/elias-jabbour/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Jabbour%20E%5BAuthor%5D%20acute%20lymphoblastic%20leukemia%20blinatumomab> ;
  onco:tag "all", "immunotherapy", "chemo-free" ;
  schema:jobTitle "Professor of Leukemia, MD Anderson Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0003-4465-6119> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/ino-vate/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ino-vate-inotuzumab-all-nejm-2016/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .